Clinical Trials Browser

OTHER × Osteosarcoma × regorafenib × Clear all

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

NCT04803877 2025-10-31

SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma

Phase 2 Active not recruiting

48 enrolled

Sarcoma

Osteosarcoma

NCT02389244 2025-09-16

REGOBONE

Phase 2 Active not recruiting

163 enrolled

Sarcoma

Chondroma, Chondrosarcoma, Osteosarcoma

NCT02048371 2023-11-07

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

Phase 2 Completed

131 enrolled 22 charts

Sarcoma

Liposarcoma, Rhabdomyosarcoma, Osteosarcoma, Chondrosarcoma, Mesenchymal

Clinical Trials

REGOSTA

SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma

REGOBONE

SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes